Pharmicell (005690)

Seoul

Currency in KRW

13,170

-60(-0.45%)

Closed·08/08

Fair Value

Unlock Value

Day's Range

13,090

13,400

52 wk Range

4,420

14,200

005690 Financial Summary

A brief financial summary of Pharmicell as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Key Ratios

P/E Ratio-18.77

Price/Book6.17

Debt / Equity13.94%

Return on Equity-29.25%

Dividend Yield0.15%

EBITDA-4.25B

Fair ValueUnlock

Fair Value UpsideUnlock

Statements Highlights

Period Ending:

2005

31/12

2006

31/12

2007

31/12

2008

31/12

2009

31/12

2010

31/12

2011

31/12

2012

31/12

2013

31/12

Income Statement

Total Revenues

aa.aa

7,217.36

10,282.42

11,111.8

33,405.39

Gross Profit

aa.aa

993.69

-1,660.67

1,257.39

8,676.66

Operating Income

aa.aa

-10,477.07

-15,379.02

-14,249.71

-7,848.03

Net Income

aa.aa

-11,859

-18,172.65

-17,642.75

-25,700.63

Balance Sheet

Total Assets

aa.aa

29,744.66

101,152.99

136,426.64

99,368.85

Total Current Liabilities

aa.aa

19,169.65

16,479.11

31,175.91

12,831.31

Total Equity

aa.aa

9,904.94

82,820.05

101,582.03

82,420.81

Cash Flow

Levered Free Cash Flow

aa.aa

-6,773.34

-12,001.95

-13,976.26

-4,199.74

Cash from Operations

aa.aa

-8,414.72

-16,166.41

-11,868.35

-2,687.73

Cash from Investing

aa.aa

-6,548.78

-890.53

-7,198.7

9,044.46

Cash from Financing

aa.aa

15,138.74

12,453.95

26,489.64

-15,738.59

Net Change in Cash

aa.aa

175.24

-4,602.98

7,422.58

-9,381.86

* In Millions of KRW (except for per share items)

Dividends

Payout Ratio

Payout ratio (TTM)

Earnings retained

EPS -613.75%

Dividend Yield

0.15%

Industry Median 0.93%

Annualised payout

20.00

Paid annually

5-Years Growth

Growth Streak

Unlock

Earnings

Latest Release

Feb 06, 2023

EPS / Forecast

-2.56 / --

Revenue / Forecast

11.93B / 17.80B

EPS Revisions

Unlock

Last 90 days

FAQ

What were Pharmicell's earnings for the latest quarter?

The Pharmicell EPS (TTM) is -613.75. Pharmicell reported sales of 3,646.14, net income of -3,249.59, and EPS of -2.56 for the latest quarter.

What was Pharmicell's net income for the latest quarter?

Pharmicell's net income for the latest quarter was -3,249.59.

How did Pharmicell's performance compare year-over-year in the latest quarter?

The company's revenue moved from 5,783.52 in the previous quarter to 3,646.14 in the latest quarter, and net income moved from -2,195.75 to -3,249.59 compared to the previous quarter.

What is Pharmicell's net profit margin on a TTM basis?

Pharmicell's trailing twelve months (TTM) net profit margin is -76.94%.

How does Pharmicell's debt to equity ratio compare to industry standards?

Pharmicell's total debt-to-equity ratio is 13.94%.

What is Pharmicell's return on investment on a TTM basis?

Pharmicell's trailing twelve months (TTM) return on investment (ROI) is -29.25%.

Did Pharmicell gain or lose cash last quarter?

In the latest quarter, Pharmicell's net change in cash was 1,517.53 million.

What were Pharmicell's total assets and liabilities in the latest quarter?

As of the latest quarter, Pharmicell reported total assets of 102,173.90 million and total liabilities of 14,018.17 million.

How has Pharmicell's total revenue grown this year?

Pharmicell's total revenue was 5,783.52 in the previous quarter and 3,646.14 in the latest quarter.

What was Pharmicell's revenue per share for the latest quarter?

Pharmicell's revenue per share for the latest quarter was 14,478.79.

NSE 30

5,327.45

-37.59

-0.70%

NSE All Share

145,756.52

-814.18

-0.56%

US 30

44,245.50

+276.8

+0.63%

US 500

6,401.30

+61.3

+0.97%

FTSE 100

9,095.73

-5.04

-0.06%

DAX

24,162.86

-29.64

-0.12%

South Africa Top 40

93,492.91

+187.14

+0.20%

Market Movers

Name	Last	Chg. %	Vol.
Access Holdings	27.60	+0.73%	55.01M
UBA	48.60	+0.31%	36.07M
Zenith Bank	74.65	-0.07%	28.81M
Dangote Cement	577.00	0.00%	13.64M
Guaranty Trust Holding	100.00	+0.05%	13.62M
MTN Nigeria	460.00	-4.17%	4.24M
Seplat Petroleum	5,450.00	0.00%	257.89K

Name	Last	Chg. %	Vol.
Champion Brew	14.41	+10.00%	2.47M
Universal Insurance PLC	1.10	+10.00%	213.19M
Union Dicon Salt	9.90	+10.00%	294.72K
Mansard Ins	14.640	+9.99%	6.40M
Guinness Nigeria	155.75	+9.99%	1.48M
Cornerst	6.41	+9.95%	14.20M
Ellah Lakes	13.28	+9.93%	30.28M

Name	Last	Chg. %	Vol.
Abbey Mortgage Bank	6.30	-9.87%	2.47M
Custodian Allied	40.45	-8.48%	3.64M
Deap Capital Management Trust	1.35	-7.53%	1.73M
Initiates	12.00	-7.34%	5.85M
Npfmcrfbk	3.200	-7.25%	3.03M
Omatek Ventures	1.35	-6.90%	10.53M
Honeywell Flour Mills Plc	24.800	-6.42%	3.39M

Trending Stocks

Name	Last	Chg. %	Vol.
Aiico	3.50	+9.72%	178.52M
Sterling Bank	8.350	+7.05%	115.27M
Initiates	12.00	-7.34%	5.85M
Guaranty Trust Holding	100.00	+0.05%	13.62M
Linkassure	2.06	+9.57%	585.56M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
A Aaaaa Aa Aaaaaa	5,450.00	+51.01%	8,230.05
Aaaaaaa Aaaaaa A	1,890.00	+34.26%	2,537.51
Aaaaaaaaaaa Aa	577.00	+28.56%	741.79
Aaaaaa Aaaa Aaa Aa	640.00	+16.43%	745.15
Aaaaa Aaaaa	74.00	+15.79%	85.68

Name	Last	Upside	Fair Value
A Aaaaa Aa Aaaaaa	5,450.00	+51.01%	8,230.05
Aaaaaaa Aaaaaa A	1,890.00	+34.26%	2,537.51
Aaaaaaaaaaa Aa	577.00	+28.56%	741.79
Aaaaaa Aaaa Aaa Aa	640.00	+16.43%	745.15
Aaaaa Aaaaa	74.00	+15.79%	85.68

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers

Popular Searches

Please try another search

Pharmicell (005690)

005690 Financial Summary

Key Ratios

Statements Highlights

Dividends

Earnings

FAQ

What were Pharmicell's earnings for the latest quarter?

What was Pharmicell's net income for the latest quarter?

How did Pharmicell's performance compare year-over-year in the latest quarter?

What is Pharmicell's net profit margin on a TTM basis?

How does Pharmicell's debt to equity ratio compare to industry standards?

What is Pharmicell's return on investment on a TTM basis?

Did Pharmicell gain or lose cash last quarter?

What were Pharmicell's total assets and liabilities in the latest quarter?

How has Pharmicell's total revenue grown this year?

What was Pharmicell's revenue per share for the latest quarter?

Trending Stocks